Analysts Reset Views On Reckitt and Barratt

Recent research updates highlight how analysts are re‑evaluating UK‑listed Reckitt Benckiser Group and Barratt Redrow, with both companies seeing modest downward revisions to fair value estimates alongside diverging broker views on future performance.

For Reckitt Benckiser Group, Simply Wall St reports that its fair value estimate has been adjusted to £64.42 per share, down from £65.63, a reduction of about £1.21. The change comes as analysts debate how the company will balance growth, portfolio reshaping and shareholder returns.

Recent price target moves underline that split view. Some research points to bullish calls around 5,900 GBp, while more cautious targets sit near 5,460 GBp. These levels frame the current analyst range on the London‑listed consumer health and hygiene group.

Jefferies raised its price target on Reckitt Benckiser to 5,900 GBp from 5,500 GBp. The firm linked the higher target to confidence in the company’s portfolio reshaping, including the Essential Home divestment, and to improved conviction in mid‑term volume and mix trends in emerging markets such as China.

Citi has reinstated coverage of Reckitt Benckiser with a Buy rating. According to the commentary, this signals that some analysts see the current valuation as reasonable when set against Reckitt’s exposure to branded consumer health and hygiene categories.

Other brokers have turned more cautious. Deutsche Bank (DBKd) lowered its price target on Reckitt Benckiser to 5,460 GBp, reflecting concerns about how the company’s existing portfolio and investment needs may translate into returns for shareholders.

RBC Capital recently downgraded the stock, highlighting that not all firms are comfortable with the current balance of risk and reward at today’s valuation and execution outlook. The contrasting moves reinforce the mixed analyst narrative around the shares.

For Barratt Redrow, Simply Wall St notes that the company’s fair value price target has been revised slightly lower from £4.67 to £4.57. Separate cautious research has cut its target from £4.70 to £4.30, signalling a reassessment of earlier assumptions.

These changes sit alongside commentary that is split between those who see present levels as more attractive and others trimming targets to reflect concerns that previous expectations may have been too optimistic for the combined housebuilder.

On the more positive side, RBC Capital recently upgraded Barratt Redrow, indicating renewed confidence in the company’s ability to execute on its plans despite earlier caution around assumptions and pricing in the sector.

Some investors may interpret the upgrade, together with the revised fair value level around £4.57, as a sign that current pricing already reflects many known risks, with potential for sentiment to improve if operational delivery meets expectations.

Peel Hunt has moved Barratt Redrow to Add from Buy and adjusted its price target to £4.30 from £4.70. The change suggests greater focus on risk and tighter valuation headroom in its assessment of the group.

Earlier, RBC Capital also cut its target by £0.25 in separate research. That revision highlighted how assumptions around growth and execution have been reassessed, pointing to a more cautious stance on the pace at which value could be realised for shareholders.